Internal standard for the quantification of GW 9662
Related Products
Unlabeled Version(s)
70785GW 9662
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

GW 9662-d5

Item No. 9000497

Product Insert (PDF)Safety Data Sheet (SDS) (PDF)
Technical Information
Formal Name
2-chloro-5-nitrobenzanilide-10,11,12,13,14-d5
Molecular Formula
C13H4ClD5N2O3
Formula Weight
281.7
Purity
≥99% deuterated forms (d1-d5)
Formulation
A crystalline solid
Solubility(Learn about Variance in Solubility)
DMF: 35 mg/mlDMF:PBS(pH7.2) (1:2): >0.5 mg/mlDMSO: 33 mg/mlEthanol: 2 mg/ml
λmax
260 nm
SMILES
ClC1=CC=C([N+]([O-])=O)C=C1C(NC2=C([2H])C([2H])=C([2H])C([2H])=C2[2H])=O
InChi Code
InChI=1S/C13H9ClN2O3/c14-12-7-6-10(16(18)19)8-11(12)13(17)15-9-4-2-1-3-5-9/h1-8H,(H,15,17)/i1D,2D,3D,4D,5D
InChi Key
DNTSIBUQMRRYIU-RALIUCGRSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Download most recent Certificate of Analysis for this product

    500 µg

    $61

    Add

    1 mg

    $112

    Add

    5 mg

    $462

    Add

    10 mg

    $807

    Add
    Product Description

    GW 9662 blocks the PPARγ-induced differentiation of monocytes to osteoclasts by >90% at a dose of 0.1 µM.1 It is therefore a much more potent antagonist than BADGE, which is another reported PPARγ antagonist.1

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Bendixen, A.C., Shevde, N.K., Dienger, K.M., et al. IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor γ1. Proc. Natl. Acad. Sci. USA 98, 2443-2448 (2001).